Home » Newsletters » BioWorld

BioWorld

Jan. 19, 1993

View Archived Issues

GENSIA APPLIES TO MARKET ARASINE IN EUROPE

MYCOGEN DEAL WITH FORAGE GENETICS

GI LICENSES FACTOR IX PROTEIN

CYTOGEN SHIPS ONCOSCINT

CANGUARD PACT WITH ATHENA

CHIRON ESTABLISHES MARKETER

AIS LICENSES ANTI-CD34 ANTIBODIES

APPLIED BIOSCIENCE CONSOLIDATES COMPANIES

PHOTODYNAMIC SKIN TUMOR TREATMENT 'EFFECTIVE'

GLAXO EXPANDS STAKE IN BIOCHEM PHARMA

VESTAR DONATES DRUG TO KS PATIENTS

SUGEN JOINS FORCES WITH SELECTIDE

CENTOCOR HALTS TRIALS; STOCK PLUMMETS

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.